The GIST Cancer Research Fund (GCRF) is a non-profit 501(C)(3) charity and was founded to support the research that is vital to the long-term survival of GIST (gastrointestinal stromal tumor) patients. GIST cancer centers and institutions across the United States depend on the funds from the GIST Cancer Research Fund to increase the understanding of what makes GIST so rare. Scientific study has helped to advance the diagnosis and treatment of GIST in children and adults but so much more is needed to someday find a cure. But this takes a lot of money to accomplish.
The GCRF team is committed to eradicating this devastating cancer through increased awareness and raising money to furthering the cause for research that is absolutely essential for GIST’s cure. We award Annual Grants to these leading cancer research institutions:
• Brigham & Women's Hospital Dana Farber Cancer Institution • Boston, MA
• Fox Chase Cancer Center • Philadelphia, PA
• Memorial-Sloan Kettering Cancer Center • New York, NY
• Oregon Health Sciences University Cancer Institute • Portland, Oregon
• University of Pittsburgh Cancer Center • Pittsburgh, PA
GCRF donates 100% of its fundraising directly to GIST cancer research. Throughout the year, the GCRF Board travels to the GIST research institutions around the country to present their grant award. Each grant presentation affords anyone touched by GIST, to a wonderful opportunity to meet and interface with the best GIST doctors and researchers in the country, as well as with their staff and the administrators of these top ranked cancer facilities that specialize in GIST. Each of the researchers provide an educational forum as part of the grant award program. This gives an opportunity to the GIST community to receive the most current information on the research work being done for GIST.
Checks Presented to Memorial Sloan Kettering GIST Cancer Research Doctors
The GIST Cancer Research Fund’s Tania and Robert Stutman attended the Memorial Sloan Kettering Cancer Center on April 1 and presented checks to MSKCC Research Doctors. Each respective doctor gave updates on the most recent research and achievements in GIST Cancer clinical treatments:
Ronald P. DeMatteo, MD, FACS, A New Therapeutic Approach in GIST, Dr. Ping Chi, MD, PhD, Targeting ETV1 in GIST and Dr. Cristina R. Antonescu, MD, Integrating Genomic Data in Wild Type & Pediatric GIST.
Tania Stutman and Dr. Cristina R. Antonescu, MD share a laugh.
A Message of Thanks for the GIST Cancer Research Fund from Jonathan A. Fletcher, MD
An update and message of thanks for the GIST Cancer Research Fund from Jonathan A. Fletcher, MD, and his team at Brigham and Women’s Hospital: (in order of appearance) Nacef Bahri, Alexandra Lauria, Meijun Zhu, MD, Bin Li, MD, PhD, Stacy Yanofsky, Armelle Dufresne, MD, PhD, Wenbin Ou, PhD, and Anastasios (Tasos) Kyriazoglou, MD, PhD.